Yih-Chih Hsu

Dr. Yih-Chih Hsu


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Cancer Letters
Verified
Journal Article
Closed access
WCWei-Hua Chen
Wei-Hua Chen
RLRumwald Leo G. Lecaros
Rumwald Leo G. Lecaros
YTYu-Cheng Tseng
Yu-Cheng Tseng
LHLeaf Huang
Leaf Huang
YHYih-Chih Hsu
Yih-Chih Hsu

1 January 2016 in Molecular Therapy
Verified
Journal Article
Open access
PDF file
RLRumwald Leo G Lecaros
Rumwald Leo G Lecaros
LHLeaf Huang
Leaf Huang
TLTsai-Chia Lee
Tsai-Chia Lee
YHYih-Chih Hsu
Yih-Chih Hsu
Photodynamic therapy (PDT) is believed to promote hypoxic conditions to tumor cells leading to overexpression of angiogenic markers such as vascular endothelial growth factor (VEGF). In this study, PDT was combined with lipid–calcium–phosphate nanoparticles (LCP NPs) to deliver VEGF-A small interfering RNA (siVEGF-A) to human head and neck squamous cell carcinoma (HNSCC) xenograft models. VEGF-A were significantly decreased for groups treated with siVEGF-A in human oral squamous cancer cell (HOSCC), SCC4 and SAS models. Cleaved caspase-3 and in situ TdT-mediated dUTP nick-end labeling assay showed more apoptotic cells and reduced Ki-67 expression for treated groups compared to phosphate buffered saline (PBS) group. Indeed, the combined therapy showed significant tumor volume decrease to ~70 and ~120% in SCC4 and SAS models as compared with untreated PBS group, respectively. In vivo toxicity study suggests no toxicity of such LCP NP delivered siVEGF-A. In summary, results suggest that PDT combined with targeted VEGF-A gene therapy could be a potential therapeutic modality to achieve enhanced therapeutic outcome for HNSCC.

13 June 2019 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
YLYu-Te Liao
Yu-Te Liao
CLChia-Hung Liu
Chia-Hung Liu
YCYin Chin
Yin Chin
SCSin-Yuan Chen
Sin-Yuan Chen
SLShing-Hwa Liu
Shing-Hwa Liu
Kevin C.-W.  WuKevin C.-W. Wu
Kevin C.-W. Wu
Herein, a cysteine-functionalized alginate was used to replace cytotoxic cetyltrimethylammonium bromide (CTAB) on gold nanorods (GNRs) by gold–thiol bonding. The characterization shows that the alginate-modified GNRs (GNR@Alg-Cys) were 137 nm in length (measured by zetasizer) with a negative surface charge (−28.4 mV). The GNR@Alg-Cys showed an intense absorption at 800 nm, indicating the potential of GNR@Alg-Cys for NIR-excited photothermal therapy (PTT). To target cancer cells, a cyclic peptide, c(RGDfK)KKK, was further modified on GNR@Alg-Cys (denoted as GNR@Alg-Cys/RGD). In vitro experiments reveal the apparently enhanced cell viability under a high dose of GNRs as well as the death of SAS-3 cell lines exposed to a single-wavelength laser (808 nm). The animal study revealed that the volume of GNR@Alg-Cys/RGD-treated laser-exposed tumor was reduced five times when compared with that in the case of the control group (PBS-treated tumor). Furthermore, the in vivo toxicity of GNR@Alg-Cys/RGD was evaluated, and no significant effect was observed on the functions of liver and kidneys after PTT.

2 December 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EGEka-Putra Gusti-Ngurah-Putu
Eka-Putra Gusti-Ngurah-Putu
Leaf HuangLeaf Huang
Leaf Huang
YHYih-Chih Hsu
Yih-Chih Hsu
Encapsulating cisplatin (CDDP) into liposomes to form lipid-platinum-chloride nanoparticles (LPC NPs) has shown a promising anticancer effect in melanoma, bladder, and liver cancer models. This promising anticancer effect of LPC NPs challenges us to study its implications in combination with photodynamic therapy (PDT). Herein, we report the therapeutic efficacy of PDT+LPC on a xenograft model of oral squamous cell carcinoma (OSCC). Results showed that PDT+LPC significantly reduced the tumor volume by up to ~112%. Meanwhile, LPC, PDT+CDDP, or the CDDP group showed ~98.8%, ~73.1%, or ~39.5% volume reductions, respectively. Histological examination suggests that PDT+LPC or LPC treatment showed minimal side effects on renal damage compared to either CDDP or the PDT+CDDP group. Immunohistochemistry staining (IHC) staining on Ki-67, CD31, cleaved caspase-3, TUNEL assays, and western blots of tumor suppressor p53 confirmed consistent results. Most importantly, PDT+LPC prolonged tumor growth inhibition, which leads to minimum chemotherapy treatment administrations. Results suggest that PDT cytotoxicity provided a potent additive effect towards chemotherapy efficacy. Therefore, combined PDT with LPC NPs enhanced the therapeutic outcome in human OSCC.

1 September 2014 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
DYDeng-Fu Yang
Deng-Fu Yang
JCJia-Haur Chen
Jia-Haur Chen
CCChun-Pin Chiang
Chun-Pin Chiang
ZHZheng Huang
Zheng Huang
JLJeng-Woei Lee
Jeng-Woei Lee
YHYih-Chih Hsu
Yih-Chih Hsu

23 November 2017 in Journal of Raman Spectroscopy
Verified
Journal Article
Closed access
PDF file
WDWei‐Yun Dai
Wei‐Yun Dai
SLSzetsen Lee
Szetsen Lee
YHYih-Chih Hsu
Yih-Chih Hsu